Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004
Expression of CD 34 and von Willebrand factor in pulmonary endothelium Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001
Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes}, Source: Eur Respir J 2012; 40: 657-664 Year: 2012
Diagnostic value of Von Willebrand factor (VWF) in patients suffering from respiratory distress Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
Endotrophin and von Willebrand factor processing as predictive markers for mortality in the ECLIPSE COPD cohort Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac) Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006
Unusually large von Willebrand factor multimers might be involved in cardiovascular events in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Endothelin, endothelial cells and von Willenbrandt factor in peripheral blood in asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003
PP308 – Endothelial injury in Chronic Obstructive Pulmonary Disease assessed by microalbuminuria (MAB) and von Willebrand factor levels and activity Source: ERS Lung Science Conference 2021 Year: 2021
Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect the severity of apnoeic episodes Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: ERS Lung Science Conference 2021 Year: 2021
The importance of high plasma levels of factor VIIIc in the severity of pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002
Cross-talk between coagulation and inflammation in COPD. The role of Factor XIII. Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Blood Krebs von den Lungen-6 predicts mortality in patients with acute exacerbation of interstitial lung disease Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005